Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carboxymethylcellulose sodium + glycerin is a combination ophthalmic preparation used primarily as an artificial tear or lubricant to provide temporary relief from burning, irritation, and discomfort due to dryness of the eye or exposure to wind and sun. Carboxymethylcellulose acts by interacting with human corneal epithelial cells to facilitate corneal wound healing and attenuate eye irritation in a dose-dependent manner. Glycerin serves as an additional lubricant and humectant that helps maintain moisture on the ocular surface. Together, these agents protect the eyes from further irritation and support ocular surface health[1][2][3][4][8]. The combination is widely used for symptomatic management of dry eye syndrome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on carboxymethylcellulose sodium + glycerin.